Human immunopathogenesis of severe acute respiratory syndrome (SARS)

Abstract Progressive immune-associated injury is a hallmark of severe acute respiratory syndrome (SARS). Viral evasion of innate immunity, hypercytokinemia and systemic immunopathology in the SARS coronavirus (SARS CoV) infected host have been suggested as possible mechanisms for the cause of severe pathology and morbidity in SARS patients. The molecular and cellular basis for how SARS CoV impacts the host immune system resulting in severe SARS, however, has not been elucidated. The variable clinical course of SARS may be the result of complex programs of host responses against the infectious agent. Therefore, the systematic analysis of innate and adaptive immune responses to SARS CoV is imperative in building as complete an immunological model as possible of host immunity and inflammatory responses during illness. Here we review recent advances in SARS immunopathogenesis research and present a summary of our findings regarding host responses in SARS patients. We contend that dysregulated type I and II interferon (IFN) responses during SARS may culminate in a failure of the switch from hyper-innate immunity to protective adaptive immune responses in the human host.

[1]  Michel Theron,et al.  An interferon‐γ‐related cytokine storm in SARS patients† , 2004, Journal of medical virology.

[2]  A. Takaoka,et al.  Interferon signalling network in innate defence , 2006, Cellular microbiology.

[3]  J. Sung,et al.  Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study , 2003, BMJ : British Medical Journal.

[4]  Mark Chappell,et al.  A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.

[5]  K. Kain,et al.  Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by Coronavirus , 2005, The Journal of infectious diseases.

[6]  Qingling Zhang,et al.  Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways , 2004, The Journal of pathology.

[7]  Arthur S Slutsky,et al.  Critically ill patients with severe acute respiratory syndrome. , 2003, JAMA.

[8]  Elizabeth Rea,et al.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. , 2003, JAMA.

[9]  Yi Guan,et al.  Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.

[10]  A. Mandavilli Open season , 2006, Nature.

[11]  Y. Lau,et al.  Pathogenesis of severe acute respiratory syndrome , 2005, Current Opinion in Immunology.

[12]  Jun Xu,et al.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. , 2005, American journal of respiratory and critical care medicine.

[13]  Anil T Ahuja,et al.  Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. , 2003, Radiology.

[14]  L. Malmgaard Induction and regulation of IFNs during viral infections. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  Arul Earnest,et al.  Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. , 2003, JAMA.

[16]  M. Loeb,et al.  Early diagnosis of SARS: lessons from the Toronto SARS outbreak , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[17]  Tzu-Hao Wang,et al.  Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV) , 2005, BMC Genomics.

[18]  B. Williams,et al.  Functional classification of interferon‐stimulated genes identified using microarrays , 2001, Journal of leukocyte biology.

[19]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[20]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[21]  J. Sung,et al.  Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. , 2003, Radiology.

[22]  A. Danchin,et al.  The Severe Acute Respiratory Syndrome , 2003 .

[23]  J. Sung,et al.  Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis , 2003, BMJ : British Medical Journal.

[24]  Renji Reghunathan,et al.  Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome , 2005, BMC Immunology.

[25]  Y. Guan,et al.  Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis , 2005, Journal of Virology.

[26]  S. Asa,et al.  Pulmonary pathology of severe acute respiratory syndrome in Toronto , 2005, Modern Pathology.

[27]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[28]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[29]  J. Sung,et al.  Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.

[30]  J. Sung,et al.  Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome , 2005, Clinical chemistry.

[31]  D. Fisher,et al.  Preventing local transmission of SARS: lessons from Singapore , 2003, The Medical journal of Australia.

[32]  M. Cameron,et al.  Gene Expression Profiling of Host Response in Models of Acute HIV Infection1 , 2004, The Journal of Immunology.

[33]  Zheng-hong Yuan,et al.  Gene expression profiles in peripheral blood mononuclear cells of SARS patients. , 2005, World journal of gastroenterology.

[34]  Pan‐Chyr Yang,et al.  Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome , 2006, Respirology.

[35]  C. Agrati,et al.  Coordinate induction of IFN-α and -γ by SARS-CoV also in the absence of virus replication , 2005, Virology.

[36]  P. Österlund,et al.  Severe Acute Respiratory Syndrome Coronavirus Fails To Activate Cytokine-Mediated Innate Immune Responses in Cultured Human Monocyte-Derived Dendritic Cells , 2005, Journal of Virology.

[37]  Paul Garner,et al.  SARS: Systematic Review of Treatment Effects , 2006, PLoS medicine.

[38]  Henry Y. H. Huang,et al.  Radiographic-clinical correlation in severe acute respiratory syndrome: study of 1373 patients in Hong Kong. , 2005, Radiology.

[39]  M. Salto‐Tellez,et al.  ARDS in SARS: cytokine mediators and treatment implications , 2004, Cytokine.

[40]  Ding-Mei Zhang,et al.  Pathogenesis of severe acute respiratory syndrome. , 2008, Chinese medical journal.